Arkolith/Insider Trading/VRTX/Form 4

Atkinson Edward Morrow III

EVP, Chief Technical Ops. Off.VERTEX PHARMACEUTICALS INC / MA (VRTX) · full profile →Form 4 · filed Feb 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$325K
Net Open-Market Flow
-$325K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2026Sell(S)668$486.35$325K18K
Feb 24, 2026Tax withholding(F)2K$485.11$789K19K

Transaction Codes

S
Open-market sale
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000875320-26-000106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML